Terumo announced it has finalized its agenda of sponsored presentations at the Annual Meeting of the Society of Thoracic Surgeons (STS) in Fort Lauderdale, Florida, January 24-27. The presentations cover topics currently of heightened interest in the cardiovascular community: controversies in aortic surgery procedures, the debate over endoscopic vein harvesting, and the role of minimized perfusion circuits in blood management.
Terumo will be represented at the STS by its three subsidiaries that develop, manufacture and market products for cardiac and vascular surgery: Terumo Cardiovascular Systems (Terumo CVS) produces products for cardiopulmonary bypass, endoscopic vessel harvesting and intraoperative monitoring; Terumo Heart Inc. produces the DuraHeart™ Left Ventricular Assist System, currently in clinical trials in the U.S.; Vascutek Ltd. is a leading manufacturer of vascular grafts. All product lines will be represented at the Terumo exhibit.
"The STS Annual Meeting is an important venue for Terumo," said Mark Sutter, President and CEO of Terumo Cardiovascular Systems. "It is one of the best opportunities for clinicians and industry to come together and exchange information that is relevant to advancing cardiovascular surgery. We are pleased to support that goal by sponsoring these speakers."
Terumo CVS and Vascutek are co-sponsoring a dinner symposium on Sunday, January 24 entitled, "Great Debates: Five Controversies in Aortic Surgery." The program features ten world renowned cardiovascular surgeons presenting opposing viewpoints on five current topics in aortic surgery. The program is moderated by Joseph Bavaria, MD, Vice Chief, Division of Cardiothoracic Surgery, University of Pennsylvania Health System. More information on the program can be found at www.terumo-cvs.com/greatdebates2010.